Sphere Fluidics
Sphere Fluidics leverages its pico-droplet microfluidics expertise to provide innovative instruments, reagents, and consumables designed to revolutionise discovery and improve efficiency.
Picodroplets inform the platforms’ core. These tiny aqueous fluid droplets encapsulate cells with a chemistry that provides biocompatible long-term stability with minimal molecule leakage, even with small molecules, including metabolites.
The company’s robustly evidenced technology — built on over a decade of scientific and engineering R&D — enables single-cell isolation, advanced analysis in biologics discovery and development as well as cell therapy engineering, synthetic biology, and more.
It has established a new direct sales and support channel for customers in North America and made several commercial leadership changes globally. Milestones achieved reflect the company’s ongoing strategic focus on operational scale-up to address demand for its Cyto-Mine® platform and provide local specialised support.
